|
abatacept 125 mg / 1 mL (1 mL INJECTION)
|
$175.6869
|
|
AUS PBS
|
generic
|
| Orencia (4) |
Bristol-Myers Squibb Australia Pty Ltd |
| Orencia ClickJect (4) |
Bristol-Myers Squibb Australia Pty Ltd |
|
|
abatacept 125 mg / 1 mL (1 mL INJECTION)
|
$770.5150
|
|
VA Big4
|
|
| ORENCIA (4) |
Bristol-Myers Squibb Company |
| ORENCIA (4) |
Bristol-Myers Squibb Company |
|
|
abatacept 125 mg / 1 mL (1 mL INJECTION)
|
$770.5150
|
|
VA FSS
|
|
| ORENCIA (4) |
Bristol-Myers Squibb Company |
| ORENCIA (4) |
Bristol-Myers Squibb Company |
|
|
abatacept 125 mg / 1 mL (1 mL INJECTION)
|
$1177.5115
|
|
NADAC
|
brand
|
| ORENCIA (1) |
E.R. Squibb & Sons, L.L.C. |
|
|
abatacept 125 mg / 1 mL (1 mL INJECTION)
|
$1177.5331
|
|
NADAC
|
brand
|
| ORENCIA (1) |
E.R. Squibb & Sons, L.L.C. |
|
|
abatacept 250 mg (INJECTION)
|
$206.4934
|
|
AUS PBS
|
generic
|
| Orencia (1) |
Bristol-Myers Squibb Australia Pty Ltd |
|
|
abatacept 250 mg / 15 mL (15 mL INJECTION)
|
$718.6500
|
|
VA Big4
|
|
| ORENCIA (1) |
Bristol-Myers Squibb Company |
|
|
abatacept 250 mg / 15 mL (15 mL INJECTION)
|
$913.1700
|
|
VA FSS
|
|
| ORENCIA (1) |
Bristol-Myers Squibb Company |
|
|
abatacept 50 mg / 0.4 mL (0.4 mL INJECTION)
|
$3082.0600
|
|
VA Big4
|
|
| ORENCIA (1) |
Bristol-Myers Squibb Company |
|
|
abatacept 50 mg / 0.4 mL (0.4 mL INJECTION)
|
$3082.0600
|
|
VA FSS
|
|
| ORENCIA (1) |
Bristol-Myers Squibb Company |
|
|
abatacept 87.5 mg / 0.7 mL (0.7 mL INJECTION)
|
$3082.0600
|
|
VA Big4
|
|
| ORENCIA (1) |
Bristol-Myers Squibb Company |
|
|
abatacept 87.5 mg / 0.7 mL (0.7 mL INJECTION)
|
$3082.0600
|
|
VA FSS
|
|
| ORENCIA (1) |
Bristol-Myers Squibb Company |
|
